Ep175: Andy Scharenberg on in vivo CAR-T cell therapies episode artwork

EPISODE · Mar 16, 2025 · 1H 10M

Ep175: Andy Scharenberg on in vivo CAR-T cell therapies

from The Long Run with Luke Timmerman · host Timmerman Report

Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.

Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.

NOW PLAYING

Ep175: Andy Scharenberg on in vivo CAR-T cell therapies

0:00 1:10:46

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Long Run with Luke Timmerman?

This episode is 1 hour and 10 minutes long.

When was this The Long Run with Luke Timmerman episode published?

This episode was published on March 16, 2025.

What is this episode about?

Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.

Can I download this The Long Run with Luke Timmerman episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!